Sign in to view content

Learnings From the Lampalizumab Chroma and Spectri Phase 3 Trials: Effect of Baseline Characteristics on Geographic Atrophy Progression

Carl D. Regillo, MD

Video
Published 2018

Related

ReCLAIM-2: Phase 2 Trial of Subcutaneous Elamipretide in Patients with Noncentral Geographic Atrophy
Jeffrey S. Heier, MD
Annual Meeting Talks
2022
Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety and Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema
Peter K. Kaiser, MD FASRS
Annual Meeting Talks
2018
Long-term Outcomes of 27-Gauge Vitrectomy-Assisted Biopsy for Molecular Prognostication in Very Small Uveal Melanoma
Tara A. McCannel, MD, PhD
Annual Meeting Talks
2018

Category: Age-Related Macular Degeneration

See more